CLOV vs EXEL · rev $1.37B vs P/E 17, rev $2.17B
Clover Health Investments Corp (CLOV) versus Exelixis Inc (EXEL) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Exelixis Inc (EXEL) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported EXEL revenue for 2025-01-03 was $2.17B. Net income was $521.3M. Revenue was up 18.5% from 2023-12-29 to 2025-01-03. EXEL currently screens at market cap $12.69B and trailing P/E 16.7.
CLOV currently screens at market cap $1.55B. EXEL currently screens at market cap $12.69B and trailing P/E 16.7.
Not investment advice. Open the CLOV and EXEL stock pages for the full models.
Not investment advice.